知镜 Cognispect · 医学文献与研究工作台

Minimally invasive hyperthermic intraperitoneal chemotherapy at the time of interval cytoreductive surgery for ovarian cancer: a case report.

Ehimiaghe E, Bonfiglio G, Hoang C, Mastroyannis SA.
Journal of surgical case reports · 2026-09-16 · PMID 42840396

文献摘要

Ovarian cancer is the second most prevalent gynecologic cancer and the leading cause of death of all gynecologic malignancies. At the time of diagnosis, most patients have advanced-stage disease and neoadjuvant chemotherapy may be used in these patients to increase the chance of optimal cytoreductive surgery (CRS). Hyperthermic intraperitoneal chemotherapy (HIPEC) at the time of interval CRS has been shown to improve both recurrence free and overall survival in eligible patients. We present a case of a patient with a BMI of 54 who underwent a minimally invasive interval cytoreduction followed by HIPEC. This case demonstrates that minimally invasive HIPEC using standard equipment is safe, feasible, and cost effective.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。